Literature DB >> 18023776

Radiation therapy toxicity to the skin.

T J Fitzgerald1, Maryann Bishop Jodoin, Gayle Tillman, Jesse Aronowitz, Richard Pieters, Susan Balducci, Joshua Meyer, M Giulia Cicchetti, Sidney Kadish, Shelagh McCauley, Joanna Sawicka, Marcia Urie, Y C Lo, Charles Mayo, Kenneth Ulin, Linda Ding, Maureen Britton, Jiayi Huang, Edward Arous.   

Abstract

Radiation therapy has been integral to cancer patient care. The skin is an intentional and unintentional target of therapy, and is sensitive to the volume of normal tissue in the radiation therapy treatment field, daily treatment dose (fractionation), and total treatment dose. We must understand the relationship of these factors to patient outcome as we move toward hypofractionation treatment strategies (radiosurgery). Chemotherapy agents and prescription medications may influence therapy-associated sequelae. Understanding this may prevent significant injury and discomfort. This article reviews established platforms of radiation therapy and sequelae associated with skin therapy. Interactions with other agents and possible predisposition to sequelae are reviewed. Skin cancer resulting from treatment and disease processes associated with possible limited outcome are also reviewed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18023776     DOI: 10.1016/j.det.2007.08.005

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  6 in total

1.  Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death.

Authors:  Panagiota A Sotiropoulou; Aurélie Candi; Guilhem Mascré; Sarah De Clercq; Khalil Kass Youssef; Gaelle Lapouge; Ellen Dahl; Claudio Semeraro; Geertrui Denecker; Jean-Christophe Marine; Cédric Blanpain
Journal:  Nat Cell Biol       Date:  2010-05-16       Impact factor: 28.824

2.  EMPACT syndrome: limited evidence despite a high-risk cohort.

Authors:  Andrew J Bishop; Maria Chang; Mario E Lacouture; Christopher A Barker
Journal:  J Neurooncol       Date:  2014-05-03       Impact factor: 4.130

3.  IL-1 generated subsequent to radiation-induced tissue injury contributes to the pathogenesis of radiodermatitis.

Authors:  Matthew Janko; Fernando Ontiveros; T J Fitzgerald; April Deng; Maria DeCicco; Kenneth L Rock
Journal:  Radiat Res       Date:  2012-08-01       Impact factor: 2.841

4.  Grade 4 radiation dermatitis presenting with full-thickness ulcerations of the groin after radiation therapy for anal squamous cell carcinoma (SCC): An example of the "bolus effect" of radiation therapy.

Authors:  Paul Blackcloud; Ellen Dabela; Marc E Grossman
Journal:  JAAD Case Rep       Date:  2015-11-02

5.  Deferoxamine to Minimize Fibrosis During Radiation Therapy.

Authors:  Ruth Tevlin; Michael T Longaker; Derrick C Wan
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-07-26       Impact factor: 4.947

6.  Radiation port cutaneous metastases: reports of two patients whose recurrent visceral cancers presented as skin lesions at the site of previous radiation and literature review.

Authors:  Brian Spencer Hoyt; Philip Randolph Cohen
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.